compound, pharmaceutical composition, methods for improving cognitive deficits, for preventing or treating cognitive deficits neurodegenerative or neuropsychiatric disorders, for the treatment or prevention of inflammatory diseases and neuropathic pain, use of a compound, and process for preparing a compound
The present invention relates to chemical compounds of formula (I), with the substituents as described in the specification, useful in the positive modulation of the alpha 7 nicotinic acetylcholine receptor (&alpha；7 nAChR). The invention also relates to the use of these compounds in the treatment or prevention of a broad range of diseases in which the positive modulation of &alpha；7 nAChR is advantageous, including neurodegenerative and neuropsychiatric diseases and also neuropathic pain and inflammatory diseases.
